Clinical Trial Update: PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial PROCLAIM-CX-2009 evaluating safe and active doses of CX-2009 for selected solid tumors; trial status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Solid Tumor

Drugs mentioned

• CX-2009

Snippet

Sponsor: CytomX Therapeutics | Conditions: Solid Tumor, Adult, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-01-05